Lv2
160 积分 2021-01-15 加入
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek
3天前
已完结
Randomized Phase II Clinical Trials
7天前
已完结
Optimal two-stage randomized phase II clinical trials
7天前
已完结
Two‐stage screened selection designs for randomized phase II trials with time‐to‐event endpoints
7天前
已完结
A Multi-Arm Multi-Stage Group Sequential Phase 2/3 Design with Dose Selection for Oncology Trials
7天前
已完结
A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials
7天前
已完结
Randomized optimal selection design for dose optimization
1个月前
已完结
On dependence assumption in p-value based multiple test procedures
1个月前
已完结
Randomized optimal selection design for dose optimization
1个月前
已关闭
A practical review of response-adaptive randomization: Under-explored challenges and potential directions
1个月前
已完结
皖公网安备34019202002308
